Trials / Completed
CompletedNCT01713504
Identification of New Markers in the Hypereosinophilic Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative and more accessible compared to those that we have already thanks to a proteomic approach. This will help the investigators to diagnose the this disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | biologie sample | comparison of biomarkers between HES, HE biomarkers data and control arms |
Timeline
- Start date
- 2010-06-29
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2012-10-24
- Last updated
- 2026-01-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01713504. Inclusion in this directory is not an endorsement.